When & How to Use Changed Clinical Laboratory Consult Codes
Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
Assay tech company shares that its Q1 2022 results were better than expected in spite of declines in COVID-19 product sales.
Recently introduced bill would require coverage of genomic cancer testing and follow-up screening for certain at-risk individuals.
With cyberattacks in the health care industry on the rise, it’s more important than ever for labs to protect patient information.
False and fraudulent claims, particularly those relating to COVID-19 and telemedicine, made up most of the key enforcement actions announced by the DOJ this past week
Senators recently introduced a bill that would require coverage for individuals with a family history of hereditary cancer.
Even when accounting for the impact of COVID-19, recent report suggests the future of direct-to-consumer genetic testing remains bright.
Study finds that three out of four blood tests produced different results depending on if they were used for White or Black people.
The DOJ recently charged defendants in nine different US districts for allegedly carrying out COVID-19 scams worth just over $149 million.
Guidelines on use of genetic testing for inherited cardiovascular diseases have been revised in accordance with 2022 testing technology.
With cyberattacks becoming increasingly common, the FDA has issued long-awaited draft guidance to help device makers deal with the threat.